Compare MRBK & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | FOCL |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | France |
| Employees | N/A | 289 |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.5M | 203.7M |
| IPO Year | 2018 | N/A |
| Metric | MRBK | FOCL |
|---|---|---|
| Price | $19.94 | $6.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.75 | N/A |
| AVG Volume (30 Days) | ★ 111.0K | 44.3K |
| Earning Date | 04-23-2026 | N/A |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 30.34 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $6,316,000.00 | N/A |
| Revenue This Year | $25.40 | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $116.59 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $13.81 | $4.76 |
| 52 Week High | $21.59 | $6.18 |
| Indicator | MRBK | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 88.29 |
| Support Level | $18.42 | $5.30 |
| Resistance Level | $20.72 | N/A |
| Average True Range (ATR) | 0.57 | 0.19 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 47.65 | 93.75 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.